Cleo Diagnostics (ASX:COV) Cash Flow from Operations : A$-2.79 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Dec. 2024, Cleo Diagnostics's Cash Receipts from Operating Activities was A$0.00 Mil. Its Cash Payments was A$-2.21 Mil. Its Dividends Paid was A$0.00 Mil. Its Dividends Received was A$0.00 Mil. Its Interest Paid was A$0.00 Mil. Its Interest Received was A$0.15 Mil. Its Taxes Refund Paid was A$0.00 Mil. And its Cash Flow from Others was A$0.00 Mil. In all, Cleo Diagnostics's Cash Flow from Operations for the six months ended in Dec. 2024 was A$-2.06 Mil.

Cleo Diagnostics Cash Flow from Operations Historical Data

The historical data trend for Cleo Diagnostics's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Cash Flow from Operations Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Jun24

Cash Flow from Operations

-0.68

-2.03

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23	Jun24	Dec24
Cash Flow from Operations	-0.25	-0.44	-1.30	-0.73	-2.06

Cleo Diagnostics Cash Flow from Operations Calculation

Cleo Diagnostics's Cash Flow from Operations for the fiscal year that ended in Jun. 2024 is calculated as:

	Cash Flow from Operations		(A: Jun. 2024 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	0.211	+	-2.59	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	0	+	0.349	+	0	+	4.4408920985006E-16
=	-2.03

Cleo Diagnostics's Cash Flow from Operations for the quarter that ended in Dec. 2024 is:

	Cash Flow from Operations		(Q: Dec. 2024 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	0	+	-2.212	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	0	+	0.152	+	0	+	0
=	-2.06

Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-2.79 Mil.

Cleo Diagnostics (ASX:COV) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Cleo Diagnostics's cash receipts from operating activities for the six months ended in Dec. 2024 was A$0.00 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Cleo Diagnostics's cash payments for the six months ended in Dec. 2024 was A$-2.21 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Cleo Diagnostics's cash payments for the six months ended in Dec. 2024 was A$0.00 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Cleo Diagnostics's cash payments for the six months ended in Dec. 2024 was A$0.00 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Cleo Diagnostics's cash payments for the six months ended in Dec. 2024 was A$0.00 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Cleo Diagnostics's cash payments for the six months ended in Dec. 2024 was A$0.15 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Cleo Diagnostics's cash payments for the six months ended in Dec. 2024 was A$0.00 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Cleo Diagnostics's cash flow from others for the six months ended in Dec. 2024 was A$0.00 Mil.

Cleo Diagnostics Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Cash Flow from Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics Headlines

No Headlines